The virus production and neutralization core for this program will prepare Venezuelan equine encephalitis virus (VEE) preparations carrying replicons for expression of HIV and SIV envelope and gag genes and will conduct HIV-1 pseudovirus neutralization assays. All of the VEE preparations used in this program will be prepared in this core. We will maintain plasmid preparations of the helper plasmids and of pVR2 for production of replicon articles preparations carrying the recombinant pVR2 genomes of interest, and characterize the replicons for infectivity, expression of the antigens, and safety recombinant pVR2 genomes of interest, and characterize the replicons for infectivity, expression of the antigens, and safety. Tittered stocks of the replicon particles will be provided to the projects for use in immunogenicity experiments. Viruses for use in the neutralization assays will be prepared for pseudotyping envelopes of interest onto particles based on the pNL4-3.luc.R- in the neutralization assays will be prepared by pseudotyping envelopes of interest onto particles based on the NL4-3.luc.R.-E-reporter genome. Neutralization assays will be conducted in microtiter in HOS-CD4-CCR5 or HOS-CD4-CXCR4 cells, using luminescence as the endpoint readout. Stocks of pseudotyped viruses will be maintained using envelope expression constructs provided by Project 1, or as available in the laboratory.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Program Projects (P01)
Project #
5P01AI048280-02
Application #
6658279
Study Section
Special Emphasis Panel (ZAI1)
Project Start
2002-09-01
Project End
2003-07-31
Budget Start
Budget End
Support Year
2
Fiscal Year
2002
Total Cost
Indirect Cost
Name
Henry M. Jackson Fdn for the Adv Mil/Med
Department
Type
DUNS #
City
Rockville
State
MD
Country
United States
Zip Code
20852
Quinnan Jr, Gerald V; Zhang, Pengfei; Dong, Ming et al. (2013) Neutralizing antibody responses in macaques induced by human immunodeficiency virus type 1 monovalent or trivalent envelope glycoproteins. PLoS One 8:e59803
Zhang, Mei-Yun; Vu, Bang K; Choudhary, Anil et al. (2008) Cross-reactive human immunodeficiency virus type 1-neutralizing human monoclonal antibody that recognizes a novel conformational epitope on gp41 and lacks reactivity against self-antigens. J Virol 82:6869-79
Choudhry, Vidita; Zhang, Mei-Yun; Sidorov, Igor A et al. (2007) Cross-reactive HIV-1 neutralizing monoclonal antibodies selected by screening of an immune human phage library against an envelope glycoprotein (gp140) isolated from a patient (R2) with broadly HIV-1 neutralizing antibodies. Virology 363:79-90
Quinnan Jr, Gerald V; Yu, Xiao-Fang; Lewis, Mark G et al. (2005) Protection of rhesus monkeys against infection with minimally pathogenic simian-human immunodeficiency virus: correlations with neutralizing antibodies and cytotoxic T cells. J Virol 79:3358-69
Zhang, Mei-Yun; Xiao, Xiaodong; Sidorov, Igor A et al. (2004) Identification and characterization of a new cross-reactive human immunodeficiency virus type 1-neutralizing human monoclonal antibody. J Virol 78:9233-42
Dong, Ming; Zhang, Peng Fei; Grieder, Franziska et al. (2003) Induction of primary virus-cross-reactive human immunodeficiency virus type 1-neutralizing antibodies in small animals by using an alphavirus-derived in vivo expression system. J Virol 77:3119-30
Kitabwalla, Moiz; Ferrantelli, Flavia; Wang, Tao et al. (2003) Primary African HIV clade A and D isolates: effective cross-clade neutralization with a quadruple combination of human monoclonal antibodies raised against clade B. AIDS Res Hum Retroviruses 19:125-31
Bouma, Peter; Leavitt, Maria; Zhang, Peng Fei et al. (2003) Multiple interactions across the surface of the gp120 core structure determine the global neutralization resistance phenotype of human immunodeficiency virus type 1. J Virol 77:8061-71
Hofmann-Lehmann, Regina; Williams, Alison L; Swenerton, Ryan K et al. (2002) Quantitation of simian cytokine and beta-chemokine mRNAs, using real-time reverse transcriptase-polymerase chain reaction: variations in expression during chronic primate lentivirus infection. AIDS Res Hum Retroviruses 18:627-39
Kong, Wei; Tian, Chunjuan; Liu, Bindong et al. (2002) Stable expression of primary human immunodeficiency virus type 1 structural gene products by use of a noncytopathic sindbis virus vector. J Virol 76:11434-9